TY  - RPRT
TI  - Preclinical characterization of mobocertinib highlights the putative therapeutic window of this novel EGFR inhibitor to EGFR exon 20 insertion mutations
AU  - Vasconcelos, P. E. N. S.
AU  - Kobayashi, I. S.
AU  - Kobayashi, S. S.
AU  - Costa, D. B.
PY  - 2020
DO  - 10.1101/2020.09.28.317560
UR  - https://www.biorxiv.org/content/10.1101/2020.09.28.317560v1
ID  - 10.1101/2020.09.28.317560
ER  -